The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.
Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and ...
The facility showcases production capacities of 100 tonne per annum (TPA) for Lactic Acid; and 60 TPA for Lactide, equivalent to 55 TPA for PLA. Commenting on the landmark development, Pramod ...
Adipo Therapeutics LLC , a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related ...
The new facility spans three acres and has production capacities of 100 tonnes per annum for Lactic Acid, 60 tonnes for lactide, and 55 tonnes for PLA. It includes fermentation, chemical synthesis ...
It showcases the capacity to produce 100 tons per annum (TPA) of lactic acid, 60 TPA of lactide, and 55 TPA of PLA. This facility marks a significant step in scaling up bio-based plastics in India.
The multilayer drug polymer coating comprises a combination of hydrophobic (PLLA: poly-L-lactic acid and PLCL: poly (L-Lactide-co-ε-Caprolac-tone)) polymers blended with sirolimus in the middle and ...
Department of Chemistry and Research Institute of Basic Science, Incheon National University, Incheon 22012, Republic of Korea ...
Nanomedicine. 2012;7(8):1225-1233. Most of the strategies described for the passage of drugs across the BBB can be enhanced by nanotechnology and some of the mechanisms involved include: NPs open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback